Explore UAB

CIDRZ 14 cropped

The Global Health Reciprocal Innovations Scientific
Working Group
aims to facilitate the exchange of innovations between low and middle-income countries (LMICs) and higher-income countries in addressing HIV challenges. Open to UAB and non-UAB individuals, it plans seminars, networking events, and capacity-building activities for program translation, implementation, and evaluation in new settings. SWG leadership provides advice on contractual and regulatory challenges.

Global Health Reciprocal Innovation (GHRI) is a recently coined term to describe the bidirectional and iterative exchange of technology, methodology, or processes between Low and Middle Income Countries (LMICs) and high-income countries to address common health challenges and provide mutual benefit.
 

Descriptive Alt Text
Model of reciprocal innovation in global health
(from Sors et al. 2022 Glob Public Health)

 

Congratulations to our 2025 GHRI Pilot Awardees

Project title: Sisters in Motion: A pilot evaluation of a community- based lifestyle program for Black women with HIV and cardiometabolic risk in Zambia and Alabama.

Team: Dr. Belinda V. Chihota (MPI - Centre for Infectious Disease Research in Zambia (CIDRZ)), Dr. Raymond Jones (MPI - UAB), Dr. Anjali Sharma (CIDRZ), Dr. Amy Goss (UAB), & Dr. Sula Mazimba (University of Virginia)

Project title: Reciprocal Innovation and Adaptation of an Eswatini AI-Powered Serious Game to Enhance Accurate HIV Risk Perception and Reduce PrEP Stigma Among Youth in Alabama

Team: Bhekumusa Lukhele (PI - UAB), Dr. Fortunate Shabalala (University of Eswatini), Dr. John Osborne (UAB), & Dr. Katia Bruxvoort (UAB)

Group Leaders

Michael Vinikoor
Michael Vinikoor, MD
Director

    
Rena Patel
Rena Patel, MD
Co-Director

    
Katia Bruxvoort
Katia Bruxvoort, PhD, MPH
Co-Director

 

Emily Knighton-Akins
Program Manager, CFAR

Acknowledge the Center

Support the UAB Center for AIDS Research by acknowledging services in publications, abstracts, and grants. Cite us: This research was supported by the University of Alabama at Birmingham (UAB) Center For AIDS Research CFAR, an NIH funded program (P30 AI027767) that was made possible by the following institutes: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, NIDDK, NIGMS, NIMHD, FIC, NIDCR, and OAR.